SIRT1 and chronic myelogenous leukemia, BCR-ABL1 positive: In chronic myelogenous leukemia (CML), SIRT1 overexpression was detected in CD34+ stem cells and implicated to increase CD34+ cell survival by suppressing TP53-mediated apoptosis of CML CSCs [52].